CONMED (CNMD)
(Delayed Data from NYSE)
$66.59 USD
+0.03 (0.05%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $66.56 -0.03 (-0.05%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth A Momentum A VGM
Conmed (CNMD) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$82.00 | $102.00 | $70.00 | 23.20% |
Price Target
Based on short-term price targets offered by eight analysts, the average price target for Conmed comes to $82.00. The forecasts range from a low of $70.00 to a high of $102.00. The average price target represents an increase of 23.2% from the last closing price of $66.56.
Analyst Price Targets (8 )
Broker Rating
Conmed currently has an average brokerage recommendation (ABR) of 2.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by eight brokerage firms. The current ABR compares to an ABR of 2.00 a month ago based on eight recommendations.
Of the eight recommendations deriving the current ABR, three are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 37.5% and 25% of all recommendations. A month ago, Strong Buy made up 37.5%, while Buy represented 25%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 |
Buy | 2 | 2 | 2 | 2 | 2 |
Hold | 3 | 3 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/1/2024 | Wells Fargo Securities | Vikramjeet S Chopra | Hold | Hold |
7/31/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
7/31/2024 | Piper Sandler | Matthew O'Brien | Strong Buy | Strong Buy |
7/25/2024 | Needham & Company | Michael Matson | Moderate Buy | Moderate Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.00 |
ABR (Last week) | 2.00 |
# of Recs in ABR | 8 |
Average Target Price | $82.00 |
LT Growth Rate | 19.30% |
Industry | Medical - Dental Supplies |
Industry Rank by ABR | 171 of 252 |
Current Quarter EPS Est: | 0.99 |
CNMD FAQs
CONMED Corporation (CNMD) currently has an average brokerage recommendation (ABR) of 2.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 8 brokerage firms.
The average price target for CONMED Corporation (CNMD) is $82.00. The current on short-term price targets is based on 6 reports.
The forecasts for CONMED Corporation (CNMD) range from a low of $70 to a high of $102. The average price target represents a increase of $23.14 from the last closing price of $66.59.
The current UPSIDE for CONMED Corporation (CNMD) is 23.14%
Based on short-term price targets offered by eight analysts, the average price target for Conmed comes to $82.00. The forecasts range from a low of $70.00 to a high of $102.00. The average price target represents an increase of 23.2% from the last closing price of $66.56.